Enantioselective synthesis of hyperparathyroidism agent Cinacalcet hydrochloride

被引:0
|
作者
Ganesh, N. S. [1 ]
Spandana, K. V. L. D. [1 ]
Narsaiah, A. Venkat [1 ]
机构
[1] CSIR, Fluoro Agrochan Dept, Organ Synth Lab, Indian Inst Chem Technol, Hyderabad 500007, India
来源
INDIAN JOURNAL OF CHEMISTRY | 2022年 / 61卷 / 05期
关键词
Wittig reaction; CBS-reduction; oxidation; reductive amination; hyperparathyroidism; CALCIMIMETIC AGENT; ALDEHYDES; EFFICIENT; ALCOHOLS; ROUTE;
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A simple and efficient route has been developed for enantioselective synthesis of hyperparathyroidism agent (R)-Cinacalcet. The synthesis started from commercially available triflouromethyl benzaldehyde and 1-(naphthalen-1-yl) ethanone and completed in 8 steps with an overall yield 18.5%. The key reactions involved are Corey-Bakshi-Shibata chiral reduction and reductive amination.
引用
收藏
页码:503 / 507
页数:5
相关论文
共 50 条
  • [1] Cinacalcet hydrochloride for the treatment of hyperparathyroidism
    Sarav, Menaka
    Sprague, Stuart M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (08): : 851 - 863
  • [2] Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride
    Sloand, James A.
    Shelly, Mark A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (05) : 832 - 837
  • [3] A novel asymmetric synthesis of cinacalcet hydrochloride
    Arava, Veera R.
    Gorentla, Laxminarasimhulu
    Dubey, Pramod K.
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2012, 8 : 1366 - 1373
  • [4] A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
    Yuichiro Ohya
    Masato Osaki
    Shota Sakai
    Shunsuke Kimura
    Chiharu Yasuda
    Tetsuro Ago
    Takanari Kitazono
    Shuji Arakawa
    BMC Neurology, 18
  • [5] A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
    Ohya, Yuichiro
    Osaki, Masato
    Sakai, Shota
    Kimura, Shunsuke
    Yasuda, Chiharu
    Ago, Tetsuro
    Kitazono, Takanari
    Arakawa, Shuji
    BMC NEUROLOGY, 2018, 18
  • [6] Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis
    Charytan, C
    Coburn, JW
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, PS
    McCary, LC
    Pichette, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) : 58 - 67
  • [7] EFFICIENT SYNTHESIS OF SUBSTANCES RELATED TO CINACALCET HYDROCHLORIDE VIA HECK COUPLING
    Lei, Fan
    Qu, Boyi
    Li, Xiaolong
    Guo, Li
    Guan, Mei
    Hai, Li
    Jin, Hui
    Wu, Yong
    SYNTHETIC COMMUNICATIONS, 2014, 44 (19) : 2879 - 2885
  • [8] Update on the use of cinacalcet in the management of primary hyperparathyroidism
    Marcocci, C.
    Cetani, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (01) : 90 - 95
  • [9] Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1
    Del Prete, M.
    Marotta, V.
    Ramundo, V.
    Marciello, F.
    Di Sarno, A.
    Esposito, R.
    Carratu, A. C.
    Di Roseto, C. De Luca
    Di Somma, C.
    Colao, A.
    Faggiano, A.
    MINERVA ENDOCRINOLOGICA, 2013, 38 (04) : 389 - 394
  • [10] Synthesis of cinacalcet hydrochloride under solvent-free conditions
    Chavakula, Ramadas
    Mutyala, Narayana Rao
    Chennupati, Srinivasa Rao
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2013, 90 (12) : 2291 - 2292